CBS News’ Weijia Jiang reported last week that the director of the National Institute of Health, Dr Francis Collins, the director of the National Institute of Allergy and Infectious Diseases, Dr Anthony Fauci and other members NIH warned Hahn against approving the emergency use authorization.Hahn conceded on Sunday that more data was needed, but said “this clearly meets the criteria we have established for emergency use authorization.”
Mr Trump, meanwhile, touted the approval as a “historic announcement” in the fight against COVID-19. Ahead of the press conference, he tweeted that he would be announcing “very good news”.
Just a day earlier, Mr Trump has suggested that the “deep state” at the FDA is deliberately slow-moving trials for a coronavirus vaccine and therapeutics, in an attempt to hurt his prospects for re-election.
“The deep condition, or whoever it is, in the FDA makes it very difficult for drug companies to get vaccines and therapies tested. Obviously, they hope to delay the response after November 3, ”he tweeted.
Former FDA Commissioner Scott Gottlieb, however,that the trial on which the authorization is based was not “done very rigorously”.